首页> 外文学位 >A novel bioabsorbable bacterial cellulose.
【24h】

A novel bioabsorbable bacterial cellulose.

机译:一种新型的生物可吸收细菌纤维素。

获取原文
获取原文并翻译 | 示例

摘要

Bacterial cellulose (BC), a polymer of glucose, is becoming one of the most effective candidates for medical uses due to its predominant ability of fluid exchange, benign degradation product and very good biocompatibility. Our current work is focused on altering non-bioabsorbable bacterial cellulose to in-body bioabsorbable bacterial cellulose (BBC).;To achieve in-body bioabsorption of BC, an enzymatic incorporating technique was used in studies to engineer a novel BC. The enzymatic incorporating technique was accomplished via a double lyophilizing process. Two methods, incorporating cellulases to BC without or along with buffer ingredients, were subsequently used to examine in-vitro biodegradability of BBC materials. The first method screened various single cellulases and their combination in terms of lifetime of cellulases in an environment presenting a suboptimal pH value (6.5--7.0). Results revealed that BBC samples containing acidic cellulases presented relatively good degradability in environments with different pH values from 4.5 to 7.4, while those BBC samples containing neutral/alkaline cellulases exhibited inverse results, suggesting that pure neutral/alkaline cellulases might not be able to work on pure BC because their substrates are usually alkali celluloses, such as carboxylmethylcellulose. The second method related to the use of buffer ingredients. Here, the incorporation of buffer ingredients to BBC material was expected to manipulate wound local pH preserving the optimal activity of cellulases. Results showed that incorporated buffer ingredients appeared to have helped form an optimal pH microenvironment for cellulases and the released glucose was accordingly increased from approximately 30% without incorporated buffer ingredients to 97% in the presence of buffer ingredients in an environment with a pH value of 7.4.;Results from subsequent in-vitro and in-vivo biocompatibility assays of BBC samples revealed a very good biocompatibility between cells examined (human fibroblast and human osteoblast) and both unmodified BC and BBC. The resulting BBC samples appeared to be more appropriate for facilitating the growth of human osteoblast, suggesting a future application of BC in bone-type tissue engineering or scaffolds.;Next, a unique spherelike structure of BC synthesized by specific cellulose producing bacterial strain (Gluconacetobacter xylinum JCM 9730) was evaluated and characterized. Cell assays of human osteoblast on these spheres exhibited good cell viability, which makes it being considered to use spherelike BC in developing specific biomedical materials, such as bone-type tissue scaffolds. These cellulose spheres varied in size from approximately 0.5 to 8 mm under different cultivation rotational speeds. The observation under field emission scanning electron microscope (FESEM) revealed that cellulose spheres obtained at 150 rpm orbitally rotational speed (ORS) were hollow with a layered outer shell, while cellulose spheres obtained at 125 rpm ORS showed a layered outer shell and an unlayered, cellulose fiber filled center. Many extraneous factors could affect the formation of spherelike BC other than the rotational speed. The results revealed that cellulose fibers left in the initial inoculu;Undoubtedly, the application of BC is always limited by its low yield and high cost. The last study, accordingly, focused on cellulose production. 1-Methylcyclopropene (1-MCP), a potent inhibitor of plant growth, was first used in this study to investigate its effect on the yield of Gluconacetobacter xylinum and its cellulose production. Results revealed that a higher biomass yield was achieved when using culture medium excluding 1-MCP while bacterial cellulose yield was low in this case. Cellulose with 15.6% more production (1-MCP added on day 1) and 25.4% more production (1-MCP added on each assigned day) was achieved when using culture medium containing 1-MCP while biomass yield was low in this case. This suggested that 1-MCP was able to impact cell activity probably because it can maintain vigorous growth of bacterial cells resulting in the enhancement of cellulose production up to 25.4% over controls. (Abstract shortened by UMI.)
机译:细菌纤维素(BC)是葡萄糖的聚合物,由于其主要的流体交换能力,良性降解产物和非常好的生物相容性,正成为医学上最有效的候选药物之一。我们目前的工作重点是将非生物吸收性细菌纤维素转变为体内生物吸收性细菌纤维素(BBC)。为了实现BC的体内生物吸收,在研究中采用了一种酶促掺入技术来设计新型BC。酶结合技术是通过双重冻干过程完成的。随后使用两种方法将纤维素酶掺入不带或不带缓冲成分的BC中,以检查BBC材料的体外生物降解能力。第一种方法是在呈现次优pH值(6.5--7.0)的环境中,根据纤维素酶的寿命筛选各种单一纤维素酶及其组合。结果显示,含有酸性纤维素酶的BBC样品在pH值从4.5到7.4的环境中表现出相对较好的降解性,而那些含有中性/碱性纤维素酶的BBC样品表现出相反的结果,表明纯中性/碱性纤维素酶可能无法在纯BC,因为它们的底物通常是碱性纤维素,例如羧甲基纤维素。第二种方法涉及缓冲成分的使用。在此,期望将缓冲成分掺入BBC材料中以操纵伤口局部pH,从而保持纤维素酶的最佳活性。结果表明,掺入缓冲液成分似乎有助于形成纤维素酶的最佳pH微环境,因此,在pH值为7.4的环境中,存在缓冲液成分时,释放的葡萄糖从未掺入缓冲液成分的大约30%增加到97%。 BBC样品随后的体外和体内生物相容性分析结果表明,所检查的细胞(人成纤维细胞和人成骨细胞)与未修饰的BC和BBC之间具有非常好的生物相容性。所得的BBC样品似乎更适合于促进人类成骨细胞的生长,表明BC将来在骨型组织工程或支架中的应用。木质素JCM 9730)进行了评估和表征。在这些球体上进行人类成骨细胞的细胞分析显示出良好的细胞活力,这使其被认为在开发特定的生物医学材料(如骨型组织支架)中使用球状BC。在不同的培养转速下,这些纤维素球的尺寸在约0.5至8mm之间变化。在场发射扫描电子显微镜(FESEM)下的观察表明,以150 rpm的轨道旋转速度(ORS)获得的纤维素纤维素球是空心的,带有一层外壳,而以125 rpm的ORS捕获的纤维素球呈现出一层外壳和未分层的结构,纤维素纤维填充中心。除旋转速度外,许多外在因素都可能影响球形BC的形成。结果表明,纤维素纤维残留在最初的接种物中;毫无疑问,BC的应用一直受到产量低,成本高的限制。因此,最后的研究集中在纤维素的生产上。 1-甲基环丙烯(1-MCP)是一种有效的植物生长抑制剂,在本研究中首先用于研究其对木糖葡糖杆菌产量及其纤维素生产的影响。结果表明,使用除1-MCP以外的培养基可获得更高的生物量产量,而在这种情况下细菌纤维素的产量较低。当使用含有1-MCP的培养基时,纤维素的产量增加了15.6%(在第1天添加了1-MCP),而产量则增加了25.4%(在每个指定的日期添加了1-MCP),而在这种情况下,生物质产量较低。这表明1-MCP之所以能够影响细胞活性,可能是因为它可以维持细菌细胞的旺盛生长,从而导致纤维素产量比对照提高了25.4%。 (摘要由UMI缩短。)

著录项

  • 作者

    Hu, Yang.;

  • 作者单位

    The Pennsylvania State University.;

  • 授予单位 The Pennsylvania State University.;
  • 学科 Engineering Biomedical.;Engineering Materials Science.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 227 p.
  • 总页数 227
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号